From molecular mimicry to cross-reactivity or pathogen expansion? A hypothesis

Clinical Rheumatology

Volumn 26, Issue 3, 2007, Pages 285-288

  Rozin, Alexander P ^a,b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Antibodies; Antiphospholipid syndrome; Cross reactivity; Infection; Molecular mimicry; Pathogen expansion

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BETA2 GLYCOPROTEIN 1; CLARITHROMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DOXYCYCLINE; HLA B27 ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN M ANTIBODY; MINOCYCLINE; PHOSPHOLIPID ANTIBODY; PLACEBO; QUINOLONE DERIVATIVE; RHEUMATOID FACTOR; RIFAMPICIN; TETRACYCLINE;

ANTIBODY RESPONSE; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIPHOSPHOLIPID SYNDROME; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; CROSS REACTION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EARLY INTERVENTION; HELICOBACTER PYLORI; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KNEE ARTHRITIS; MOLECULAR MIMICRY; NONHUMAN; PRIORITY JOURNAL; REMISSION; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SAPHO SYNDROME; SPONDYLOARTHROPATHY; T LYMPHOCYTE; UNSPECIFIED SIDE EFFECT;

ANTIPHOSPHOLIPID SYNDROME; BACTERIAL INFECTIONS; CROSS REACTIONS; HUMANS; MOLECULAR MIMICRY;

EID: 33947651656     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0352-9     Document Type: Review

References (23)

1. Shoenfeld Y, Blank M, Cervera R, Font J, Raschi E, Meroni PL (2006) Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis 65:2-6
2. Cervera R, Asherson RA, Acevedo ML, Gomez-Puerta JA, Espinosa G, de la Red G et al (2004) Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis 63:1312-1317
3. Gharavi AE, Pierangeli SS, Espinola RG, Liu X, Colden-Stanfield M, Harris EN (2002) Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo. Arthritis Rheum 46:545-552
4. Zhang L, Jacobsson K, Strom K, Lindberg M, Frykberg L (1999) Staphylococcus aureus express a cell surface protein that binds both IgG and beta2-glycoprotein I. Microbiology 145:177-183
5. Elkayam O, Segal R, Lidgi M, Caspi D (2005) Positive anti-cyclic citrullinated proteins and Rheumatoid Factor during active lung Tuberculosis. Ann Rheum Dis (in press) Dec 16
6. Elkayam O, Burke M, Vardinon N, Zakut V, Yitzhak RB, Paran D et al (2005) Autoantibodies profile of rheumatoid arthritis patients during treatment with Infliximab. Autoimmunity 38:155-160
7. Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernandez-Sueiro JL et al (1994) The germ-free state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 180:2359-2364
8. Khare SD, Luthra HS, Davis CS (1995) Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: A model of human spondyloarthropathies. J Exp Med 182:1153-1158
9. Kuo CC, Gown AM, Benditt EP, Grayston JT (1993) Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb 13:1501-1504
10. Shi Y, Tokunaga O (2002) Chlamydia pneumonia and multiple infections in the aorta contribute to atherosclerosis. Pathol Int 52:755-763
11. Blessing E, Campbell LA, Rosenfeld ME, Chesebro B, Kuo CC (2005) A 6-week course of azithromycin treatment has no beneficial effect on atherosclerotic lesion development in apolipoprotein E-deficient mice chronically infected with Chlamydia pneumoniae. J Antimicrob Chemother 55:1037-1040
12. Carter JD, Valeriano J, Vasey FB (2004) Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to Chlamydia-induced arthritis. A prospective, randomized 9-month comparison. J Rheumatol 31:1973-1980
13. Breebaart AC, Bijlsma JW, van Eden W (2002) 16-year remission of rheumatoid arthritis after unusually vigorous treatment of closed dental foci. Clin Exp Rheumatol 20:555-557
14. O'Dell JR, Blakely KW, Mallek JA, Eckhoff PJ, Leff RD, Wees SJ et al (2001) Treatment of early rheumatoid arthritis with minocycline or placebo: Results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 44:2235-2241
15. Newkirk MM, Goldbach-Mansky R, Senior BW, Klippel J, Schumacher HR Jr, El-Gabalawy HS (2005) Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherechia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis. Rheumatology (Oxford) 44:1433-1441
16. Rozin AP, Nahir AM (2006) Is SAPHO syndrome a target for antibiotic therapy? Clin Rheumatol (in press) Apr 7
17. Sapir T, Shoenfeld Y (2005) Facing the enigma of immunomodulatory effects of intravenous immunoglobulin. Clin Rev Allergy Immunol 29:185-200
18. Blank M, George J, Fishman P, Levy Y, Tober V, Savion S et al (1998) Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression. Arthritis Rheum 41:224-232
19. Rozin AP, Schapira D, Bergman R (2003) Alopecia areata and relapsing polychondritis or mosaic of autoimmunity? The first experience of co-trimoxazole treatment. Ann Rheum Dis 62:778-780
20. Rozin AP (2005) Is Behcet's syndrome associated with infection? Ann Rheum Dis 64:513-514
21. Rozin AP, Militianu D, Edoute Y (2004) OARSI response criteria in assessment of co-trimoxazole influence on refractory knee osteoarthritis during prophylaxis of recurrent UTI. Ann Rheum Dis Sup 1(63):358
22. Saviola G, Abdi Ali L, Rossini P, Campostrini L, Coppini A, Gori M et al (2002) Clarithromycin in rheumatoid arthritis patients not responsive to disease-modifying antirheumatic drugs: An open, uncontrolled pilot study. Clin Exp Rheumatol 20:373-378
23. Saviola G, Abdi Ali L, Shams Eddin S, Davoli C, Taglietti M (2004) Clarithromycin in adult-onset Still's disease. Case report with a 1-year follow-up. Clin Exp Rheumatol 22:379